Emerging infectious diseases · 2021 · 20 citations · 6 references
Public HealthPharmacologyTuberculosis ControlAntimicrobial Susceptibility TestingMycobacterial DiagnosticsTuberculosis CareTuberculosis DiagnosisTuberculosis Diagnostic TestingAnti-tuberculosis Drug RepurposingDrug Resistance TestingMycobacterium Tuberculosis InfectionPhenotypic Drug Susceptibility TestingPhenotypic Susceptibility AssessmentTuberculosis Drug Resistance
We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited.
6
Claudio U. Köser, Florian P. Maurer, Katharina Kranzer · International Journal of Infectious Diseases · 2019 · 44 citations · Full text
Koné Kaniga, Akio Aono, Emanuele Borroni et al. · Journal of Clinical Microbiology · 2020 · 41 citations · Full text
Veterinary Medicine, Pharmacology, Clinical Pharmacology +15
Vladyslav Nikolayevskyy, Doris Hillemann, Elvira Richter et al. · PLoS ONE · 2016 · 34 citations · Full text
Public Health, Infectious Disease Control, Internal Medicine +17